Difference between revisions of "Team:Queens Canada/Market"

Revision as of 02:42, 14 October 2018

Market Direction Analysis

wirelessLum Following our interview series, we reflected on all the insight we had gained from the various experts, parents, and community members. We came to the conclusion, that the use of the diagnostic pacifier device, was perhaps not best fit in the hands of all parents, because they may lack the scientific literacy to properly interpret fluctuations in their child's hormone levels. Ultimately, we weighed impact and feasibility in our design and proposed the following go to market-strategy for our device, detailed in the graph and table below. Most immediately, the technology we worked on developing this year could be best utilized by researchers for the immediate quantification of hormones in samples, following appropriate testing and clinical trials this device could benefit researchers as a non-invasive method of measuring salivary analytes. After the product has gained validation by clinicans, we would hope that the device could be used for non-verbally expressive individuals, such as those suffering from neurodevelopmental disorders to gauge well-being. Additionally, this device may have application in those suffering from neurodegenerative disease as a tool to gauge their well-being. Lastly, if the device is approved for such an indication, it may benefit wider audiences to track hormone levels and gain greater visibility to their endocrine health.

Market Direction Analysis Summary

Use by parents to monitor child’s stress levels and general well-being

Pros

Can remove any communication barriers between parent and child
Ability to measure Δ cortisol could be useful in evaluating changes over time
Useful in the early detection of illness and prevention of Sudden Infant Death Syndrome (SIDS)

Cons

Continual monitoring may lead to more anxiety in parents
Expensive technology
Difficulties in establishing a baseline
Knowing the information does not have a substantial effect; minimal chance for intervention

Used as a dignostic test in clinical settings

Pros

Non-invasive procedure
Instant results could facilitate faster diagnosis leading to earlier intervention plans
Could help reduce extensive wait times in clinics or Emergency Room (ER)
Little training required to operate, would reduce the need for highly trained personnel

Cons

Concerns about biomarkers in saliva being as accurate as plasma samples
Sensitivity and specificity must be very high for proper diagnosis

Use in monitoring treatment in clinical settings

Pros

Non-invasive method Instant and ongoingsurveillance
Could be used to evaluate metabolism of hormone
Help to determine personalised treatment plan and dosage
Could be useful in determining effectiveness of a treatment

Cons

Concerns about biomarkers in saliva being as accurate as plasma samples
Expensive to replace cartridges

Used in research studies to monitor levels of specific biomarker(s) in saliva

Pros

Could replace disruptive method of salivary collection
Could reveal critical information missed in current studies
Easier to complete studies with young children and infants

Cons

Would need different designs that don’t interrupt the studies and are less noticeable
Would need different designs to use in studies with people of all ages
Must be incredibly sensitive and specific for the desired biomarker

@@ Line 171: / Line 171: @@
 <h2 style="width:70%;margin-left:15%">Market Direction Analysis</h2>
 <br>
 <p style="width:1200px;margin-left:12%">
-<br>
 <img src="https://static.igem.org/mediawiki/2018/b/bb/T--Queens_Canada--marketstrategy.png" alt='wirelessLum' style="height=50%"/>
 Following our interview series, we reflected on all the insight we had gained from the various experts, parents, and community members. We came to the conclusion, that the use of the diagnostic pacifier device, was perhaps not best fit in the hands of all parents, because they may lack the scientific literacy to properly interpret fluctuations in their child's hormone levels.
 Ultimately, we weighed impact and feasibility in our design and proposed the following go to market-strategy for our device, detailed in the graph and table below. Most immediately, the technology we worked on developing this year could be best utilized by researchers for the immediate quantification of hormones in samples, following appropriate testing and clinical trials this device could benefit researchers as a non-invasive method of measuring salivary analytes. After the product has gained validation by clinicans, we would hope that the device could be used for non-verbally expressive individuals, such as those suffering from neurodevelopmental disorders to gauge well-being. Additionally, this device may have application in those suffering from neurodegenerative disease as a tool to gauge their well-being. Lastly, if the device is approved for such an indication, it may benefit wider audiences to track hormone levels and gain greater visibility to their endocrine health.
 </p>
+<h4 style="width:70%;margin-left:15%">Market Direction Analysis Summary</h4>
 <br>
-<h4 style="width:70%;margin-left:15%">Market Direction Analysis Summary</h4>
-<br><br>
 <div class="timeline" style="width:70%;margin-left:15%">